These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Genome characteristics of Ben Fraj I; Bouchez V; Smaoui H; Kechrid A; Brisse S J Med Microbiol; 2019 Sep; 68(9):1320-1323. PubMed ID: 31329091 [TBL] [Abstract][Full Text] [Related]
24. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264 [TBL] [Abstract][Full Text] [Related]
25. [Antigenic variability of Bordetella pertussis strains isolated in 1967-2010 in the Czech Republic--possible explanation for the rise in cases of pertussis?]. Zavadilová J; Lžičařová D; Musílek M; Křížová P; Fabiánová K Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):130-8. PubMed ID: 26448300 [TBL] [Abstract][Full Text] [Related]
26. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409 [TBL] [Abstract][Full Text] [Related]
27. Bordetella pertussis, Finland and France. Caro V; Elomaa A; Brun D; Mertsola J; He Q; Guiso N Emerg Infect Dis; 2006 Jun; 12(6):987-9. PubMed ID: 16707058 [TBL] [Abstract][Full Text] [Related]
28. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Zeddeman A; van Gent M; Heuvelman CJ; van der Heide HG; Bart MJ; Advani A; Hallander HO; Wirsing von Konig CH; Riffelman M; Storsaeter J; Vestrheim DF; Dalby T; Krogfelt KA; Fry NK; Barkoff AM; Mertsola J; He Q; Mooi F Euro Surveill; 2014 Aug; 19(33):. PubMed ID: 25166348 [TBL] [Abstract][Full Text] [Related]
29. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange. Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455 [TBL] [Abstract][Full Text] [Related]
30. Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Boursaux-Eude C; Thiberge S; Carletti G; Guiso N Vaccine; 1999 Jun; 17(20-21):2651-60. PubMed ID: 10418915 [TBL] [Abstract][Full Text] [Related]
31. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013. Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130 [TBL] [Abstract][Full Text] [Related]
33. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. Clarke M; McIntyre PB; Blyth CC; Wood N; Octavia S; Sintchenko V; Giles L; Quinn H; Hill V; Hanly G; Lan R; Marshall HS J Infect; 2016 Feb; 72(2):171-8. PubMed ID: 26675318 [TBL] [Abstract][Full Text] [Related]
34. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Hegerle N; Dore G; Guiso N Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274 [TBL] [Abstract][Full Text] [Related]
35. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012. Bailon H; León-Janampa N; Padilla C; Hozbor D BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444 [TBL] [Abstract][Full Text] [Related]
36. [Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process]. Mazurova IK; Borisova OIu; Kombarova SIu; Zakharova NS; Aleshkin VA Mol Gen Mikrobiol Virusol; 2005; (4):21-5. PubMed ID: 16334221 [TBL] [Abstract][Full Text] [Related]
37. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908 [TBL] [Abstract][Full Text] [Related]
38. Bordetella parapertussis isolates not expressing pertactin circulating in France. Bouchez V; Brun D; Dore G; Njamkepo E; Guiso N Clin Microbiol Infect; 2011 May; 17(5):675-82. PubMed ID: 20636430 [TBL] [Abstract][Full Text] [Related]
39. Small mutations in Bordetella pertussis are associated with selective sweeps. van Gent M; Bart MJ; van der Heide HG; Heuvelman KJ; Mooi FR PLoS One; 2012; 7(9):e46407. PubMed ID: 23029513 [TBL] [Abstract][Full Text] [Related]
40. Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994. Peppler MS; Kuny S; Nevesinjac A; Rogers C; de Moissac YR; Knowles K; Lorange M; De Serres G; Talbot J J Clin Microbiol; 2003 Jul; 41(7):3344-7. PubMed ID: 12843089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]